Africa Must Reduce Reliance on Imported Medicines, World Health Organization (WHO) Urges at Regional Good Manufacturing Practices (GMP) Training Workshop
The two-day hands-on workshop, held from 22–23 July 2025, brought together 26 participants from National Regulatory Authorities (NRAs) and pharmaceutical manufacturers across seven East African Community (EAC) member states. It was jointly organized by the Local Production and Assistance Unit in WHO Headquarters, the WHO Regional Office for Africa (AFRO), and the WHO Country Office in Ethiopia, with financial support from The Global Fund to Fight AIDS, Tuberculosis and Malaria.
Designed to strengthen technical capacities in GMP implementation, the training offered a mix of instructional content and case-based learning. Core topics included Quality Management Systems, Quality Risk Management, Corrective and Preventive Actions (CAPA), data integrity, validation practices, and management of critical utility systems such as water and HVAC. The approach strengthened practical skills in complying with current WHO GMP standards and fostered active collaboration between regulatory bodies and industry professionals, enhancing mutual understanding and shared responsibility for quality-assured pharmaceutical production.
Dr Jicui Dong, Unit Head of the WHO Local Production and Assistance Unit, remarked 'Compliance with current GMP standards needs both theoretical knowledge and practical skills. It is encouraging to see the commitment of pharmaceutical manufacturers within this region to invest in workforce development and ensure local production of quality pharmaceuticals.'
Opening the workshop, Mr Dejene Daba, Head of the Medicine Manufacturers Inspection and Enforcement Desk at the Ethiopian Food and Drug Authority (EFDA), reaffirmed the agency's commitment to supporting manufacturers and attaining WHO Maturity Level 3 regulatory status—a benchmark for robust regulatory systems.
Dr Kaluwa underscored that reliance on imported medicines continues to pose significant health security risks for African countries, particularly in times of global supply chain disruptions. 'Enhancing local pharmaceutical production is not only a strategic health priority but also an economic and political imperative,' he said.
The workshop represents a concrete step toward building regional capabilities to meet international manufacturing standards, aligning with broader continental goals such as the African Union and Africa CDC.
Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
5 hours ago
- Zawya
Africa Must Reduce Reliance on Imported Medicines, World Health Organization (WHO) Urges at Regional Good Manufacturing Practices (GMP) Training Workshop
Africa must prioritize pharmaceutical self-reliance by boosting local medicine production rooted in global quality standards, said Dr Owen Laws Kaluwa, WHO Representative to Ethiopia, in a keynote address delivered at a regional training workshop on Good Manufacturing Practices (GMP) held in Addis Ababa. The two-day hands-on workshop, held from 22–23 July 2025, brought together 26 participants from National Regulatory Authorities (NRAs) and pharmaceutical manufacturers across seven East African Community (EAC) member states. It was jointly organized by the Local Production and Assistance Unit in WHO Headquarters, the WHO Regional Office for Africa (AFRO), and the WHO Country Office in Ethiopia, with financial support from The Global Fund to Fight AIDS, Tuberculosis and Malaria. Designed to strengthen technical capacities in GMP implementation, the training offered a mix of instructional content and case-based learning. Core topics included Quality Management Systems, Quality Risk Management, Corrective and Preventive Actions (CAPA), data integrity, validation practices, and management of critical utility systems such as water and HVAC. The approach strengthened practical skills in complying with current WHO GMP standards and fostered active collaboration between regulatory bodies and industry professionals, enhancing mutual understanding and shared responsibility for quality-assured pharmaceutical production. Dr Jicui Dong, Unit Head of the WHO Local Production and Assistance Unit, remarked 'Compliance with current GMP standards needs both theoretical knowledge and practical skills. It is encouraging to see the commitment of pharmaceutical manufacturers within this region to invest in workforce development and ensure local production of quality pharmaceuticals.' Opening the workshop, Mr Dejene Daba, Head of the Medicine Manufacturers Inspection and Enforcement Desk at the Ethiopian Food and Drug Authority (EFDA), reaffirmed the agency's commitment to supporting manufacturers and attaining WHO Maturity Level 3 regulatory status—a benchmark for robust regulatory systems. Dr Kaluwa underscored that reliance on imported medicines continues to pose significant health security risks for African countries, particularly in times of global supply chain disruptions. 'Enhancing local pharmaceutical production is not only a strategic health priority but also an economic and political imperative,' he said. The workshop represents a concrete step toward building regional capabilities to meet international manufacturing standards, aligning with broader continental goals such as the African Union and Africa CDC. Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Zawya
5 hours ago
- Zawya
Egypt: Capital Med plans EGX listing to raise up to $41mln in Q3
Arab Finance: Capital Med, the medical city project in Badr City, is preparing to list a stake on the Egyptian Exchange (EGX) before the end of the third quarter (Q3) of 2025, aiming to raise as much as EGP 2 billion, unnamed sources told Al Borsa News. Proceeds from the planned listing will be used to help finance the second phase of the medical complex, which is expected to cost between EGP 3 billion and EGP 5 billion. Al Ahly Pharos has been tapped to manage and promote the offering. The company announced in February that it would debut on the EGX through a direct listing in the first half (H1) of 2025, followed by a capital increase to support construction of the new phase of the project. © 2025 All Rights Reserved Arab Finance For Information Technology Provided by SyndiGate Media Inc. (
Zawya
8 hours ago
- Zawya
Rapid response halts diphtheria outbreak among refugees in Mauritania
When children in Mberra refugee camp began arriving at health posts with sore throats, low-grade fevers and swollen necks early this year, health workers feared the worst. Within days, breathing difficulties and the tell-tale thick grey coating in some throats confirmed an outbreak of diphtheria. In a densely populated refugee setting with limited health infrastructure, even a handful of cases could quickly spiral into crisis. Mauritania's Ministry of Health, supported by the World Health Organization (WHO) and humanitarian partners, moved fast. Within 72 hours of laboratory confirmation, a full outbreak response was under way. Between July and September 2024, at least ten cases of diphtheria, including two deaths, were recorded in the Mberra camp. Of these cases, eight were in children, six of whom were under five years of age, all of whom were unvaccinated. In response, more than a thousand people were vaccinated, including nearly 70 health professionals. In addition, over two tonnes of emergency supplies were delivered to the camp, including antitoxins, antibiotics, personal protective equipment and disinfectants. WHO deployed technical experts to support case investigation, contact tracing and coordination with national and local teams. Community health workers were rapidly trained to identify symptoms, isolate cases and provide prevention education to families. 'Before the training, many of us had never seen a case of diphtheria,' says Fatou, a community health volunteer. 'Now we know what to look for, and how to respond.' A targeted risk communication and community engagement campaign used megaphones, posters and local radio in multiple languages to build trust, educate communities and ensure early reporting of symptoms. Thanks to this rapid, coordinated approach, the outbreak was contained within weeks. No deaths were reported, and all cases remained confined to the initial cluster. "This was a textbook example of what rapid mobilization and partnership can achieve," says Dr Charlotte Faty Ndiaye, WHO Representative in Mauritania. "In a fragile setting like Mberra, early action saved lives." The experience underlined the importance of preparedness, coordination and community engagement in humanitarian contexts. WHO and partners, working hand-in-hand with Mauritania's Ministry of Health, turned a looming health emergency into an example of public health equity in action. Awareness-raising campaigns were carried out in communities and among humanitarian personnel to encourage vaccination, with a particular focus on diphtheria prevention. Between July 2024 to May 2025, more than 2300 newly arrived individuals at Mberra camp were vaccinated. Distributed by APO Group on behalf of World Health Organization (WHO) - Mauritania.
